Who owns GAIN THERAPEUTICS INC?
- Ticker: GANX
- CUSIP Number: 36269b105
Tip: Access positions for across all investors
Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gain Therapeutics stock
Who bought or sold GAIN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Marshall Wace | 1.9M | $3.9M | 9% | Jun 2026 |
|
| Potomac Capital Management | 946k | $1.9M | -6% | Jun 2026 |
|
| GSA Capital Partners | 632k | $1.3M | 102% | Jun 2026 |
|
| Jones Financial Companies, L.L | 609k | $1.1M | -4% | Jun 2026 |
|
| Cambridge Investment Research Advisors | 569k | $1.2M | 0% | Jun 2026 |
|
| DME Capital Management | 566k | $1.1M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 480k | $975k | 20% | Jun 2026 |
|
| Geode Capital Management | 454k | $922k | 1% | Jun 2026 |
|
| BlackRock | 275k | $558k | 22% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 232k | $470k | 1% | Jun 2026 |
|
| UBS Group | 215k | $437k | -2% | Jun 2026 |
|
| Stratos Wealth Partners | 200k | $406k | 52% | Jun 2026 |
|
| Citadel Advisors | 195k | $396k | 176% | Jun 2026 |
|
| Cresset Asset Management | 160k | $325k | 0% | Jun 2026 |
|
| State Street Corporation | 158k | $306k | 0% | Mar 2026 |
|
| Susquehanna International | 143k | $290k | -70% | Jun 2026 |
|
| Morgan Stanley | 140k | $271k | -5% | Mar 2026 |
|
| Squarepoint Ops | 136k | $277k | 100% | Jun 2026 |
|
| LPL Financial | 117k | $238k | 12% | Jun 2026 |
|
| Jane Street | 97k | $197k | -62% | Jun 2026 |
|
| Northern Trust | 97k | $197k | -15% | Jun 2026 |
|
| Commonwealth Equity Services | 59k | $119k | 97% | Jun 2026 |
|
| XTX Topco | 55k | $112k | 100% | Jun 2026 |
|
| Springbok Capital Management | 36k | $73k | 0% | Jun 2026 |
|
| Benedict Financial Advisors | 35k | $71k | 126% | Jun 2026 |
|
| Bridgeway Capital Management | 30k | $61k | 0% | Jun 2026 |
|
| Apollon Wealth Management | 27k | $54k | 0% | Jun 2026 |
|
| Virtu Financial | 21k | $43k | 97% | Jun 2026 |
|
| Oliver Luxxe Assets | 20k | $41k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 18k | $37k | 0% | Jun 2026 |
|
| HighTower Advisors | 17k | $35k | 100% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 17k | $31k | 100% | Jun 2026 |
|
| Sontag Advisory | 17k | $34k | 0% | Jun 2026 |
|
| Sandhill Capital Partners | 15k | $31k | 0% | Jun 2026 |
|
| Millington Financial Advisors | 15k | $26k | 0% | Jun 2026 |
|
| HB Wealth Management | 13k | $26k | 100% | Jun 2026 |
|
| Two Sigma Securities | 13k | $26k | 100% | Jun 2026 |
|
| Harbour Investments | 11k | $22k | 100% | Jun 2026 |
|
| Goss Wealth Management | 11k | $22k | 0% | Jun 2026 |
|
| Mercer Global Advisors | 10k | $20k | 100% | Jun 2026 |
|
| Sanctuary Advisors | 10k | $20k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 9.4k | $19k | -15% | Jun 2026 |
|
| Tower Research Capital | 8.3k | $17k | 51% | Jun 2026 |
|
| Group One Trading | 3.8k | $7.7k | -41% | Jun 2026 |
|
| Advisor Group Holdings | 2.0k | $4.1k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 1.7k | $3.4k | 100% | Jun 2026 |
|
| SRS Capital Advisors | 1.7k | $3.5k | 100% | Jun 2026 |
|
| Barclays | 1.4k | $2.7k | 100% | Jun 2026 |
|
| Caitong International Asset Management | 165.00 | $334.999500 | 100% | Jun 2026 |
|
| Larson Financial Group | 10.00 | $20.000000 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
Who sold out of Gain Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Mar 2026 | 25k | $48k |
| Simplex Trading | Mar 2026 | 13k | $26k |
| Kestra Advisory Services | Mar 2026 | 12k | $23k |